Old Web
English
Sign In
Acemap
>
authorDetail
>
Jordan Kraaijenhof
Jordan Kraaijenhof
University of Amsterdam
Medicine
Dipeptidyl peptidase-4
Type 2 diabetes
Sulfonylurea
Linagliptin
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The iterative lipid impact on inflammation in atherosclerosis
2021
Current Opinion in Lipidology
Jordan Kraaijenhof
G. Kees Hovingh
Erik S.G. Stroes
Jeffrey Kroon
Show All
Source
Cite
Save
Citations (1)
Author response for "Effects of DPP ‐4 inhibitor linagliptin versus sulfonylurea glimepiride on systemic haemodynamics in overweight patient with type 2 diabetes: a secondary analysis of an 8‐week randomized controlled double‐blind trial"
2020
Diabetes, Obesity and Metabolism
Jordan Kraaijenhof
Marcel H.A. Muskiet
Lennart Tonneijck
D. Margriet Ouwens
Mark H. H. Kramer
Daniël H. van Raalte
Mark M. Smits
Show All
Source
Cite
Save
Citations (0)
Effects of DPP-4 inhibitor linagliptin versus sulfonylurea glimepiride on systemic haemodynamics in overweight patient with type 2 diabetes: a secondary analysis of an 8-week randomized controlled double-blind trial.
2020
Diabetes, Obesity and Metabolism
Jordan Kraaijenhof
Marcel H.A. Muskiet
Lennart Tonneijck
D. Margriet Ouwens
Mark H.H. Kramer
Daniël H. van Raalte
Mark M. Smits
Show All
Source
Cite
Save
Citations (3)
1